We are monitoring the impact of COVID-19 on North America Dendritic Cell Cancer Vaccines Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5266
Share on
Share on

North America Dendritic Cell Cancer Vaccines Market Research Report – Segmented By Product Type, End User & Country (US, Canada & Rest of North America) - Industry Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: February, 2020
ID: 5266
Pages: 145

North America Dendritic Cell Cancer Vaccines Market Size & Growth (2019 – 2024):

As Per the Report, the Size of the North America Dendritic Cell Cancer Vaccines Market is valued at USD xx billion in 2019 and is projected to grow at a CAGR of xx%, to reach USD xx billion by 2024 during the forecast period 2019-2024.

Leukocytes of a very rare kind are termed as Dendritic cells (DCs). They are highly effective in providing antigens to T cells. If kept isolated and administered tumor antigen ex vivo then DCs if administered as a cellular vaccine are found to enhance immunity in animals. They are found in lymphoid organs. Enhancement in immunity comes from the secretion of cytokines. As of now, cancer treatment relies heavily on radiation, chemo, etc. DCS is adaptable and hence provides flexibility in the treatment of different kinds of cancer.

An increasing number of cases of people suffering from cancer, better availability of treatment methods, rising healthcare expenditure, savory government policies and heavy investments in R&D, and improving success rates of clinical trials are the primary factors driving the growth of this market. Augmenting the geriatric population, rapid advancements in technology and the ability to combat several cancer antigens are the secondary factors fuelling market growth.

Little or no penetration of DC vaccines in remote areas, strict administrative and regulatory frameworks, and ambiguity over the results of the clinical trials on these vaccines are the primary restraints of market growth.

North America Dendritic Cell Cancer Vaccines Market has been segmented and sub-segmented into the following categories

  • By Product Type: CreaVax, Sipuleucel-T (Provenge).
  • By End User: Pediatrics, Adults.
  • By Country: US, Canada & Rest of North America.

On the basis of product type, the Provenge was the first DC vaccine that was introduced in the market. So naturally, it follows that it is the market leader and is expected to remain so until the end of the forecast period. It treats melanoma, prostate cancer etc. It was approved by the FDA nearly seven years ago.

On the basis of region, North America captured the highest market share. US lead the market in this region.

Promising Companies leading the North America Dendritic Cell Cancer Vaccines Market Profiled in the Report are 3M Company, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime, Sanpower Corporation (Dendreon Corporation). Other players in the market include Elios Therapeutics. ImmunoCellular Therapeutics, Immunicum, Kiromic, Medigene, Merck & co, Northwest Biotherapeutics, Glaxo Smith Kline, ImmunoCellular Therapeutics, Tella Incorporation, and Vaxil BioTherapeutics.

1.Introduction         

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Product Type    

       5.1.1 Introduction           

       5.1.2 CreaVax   

       5.1.3 Sipuleucel-T (Provenge)    

       5.1.4 Others      

       5.1.5  Y-o-Y Growth Analysis, By Product Type   

       5.1.6  Market Attractiveness Analysis, By Product Type 

       5.1.7  Market Share Analysis, By Product Type   

                5.2 End User                      

       5.2.1 Introduction           

       5.2.2 Pediatrics 

       5.2.3 Adults       

       5.2.4 Y-o-Y Growth Analysis, By End User             

       5.2.5 Market Attractiveness Analysis, By End User           

       5.2.6 Market Share Analysis, By End User             

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Product Type

                       6.1.3.3 By End User

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Product Type

                       6.1.4.3 By End User

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Product Type

                       6.1.5.3 By End User

                6.2 United States   

                6.3 Canada                         

7. Strategic Analysis              

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis               

                8.1 3M Company    

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Activarti                       

                8.3 Argos Therapeutics                 

                8.4 Batavia Bioservices                  

                8.5 Bellicum Pharmaceuticals                     

                8.6 Creagene                    

                8.7 DanDrit Biotech                        

                8.8 DCPrime                      

                8.9 Sanpower Corporation (Dendreon Corporation)                        

                8.10 Elios Therapeutics                 

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables                

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Billion )
  2. North America CreaVax Market By Region, From 2019-2024 ( USD Billion )
  3. North America Sipuleucel-T (Provenge) Market By Region, From 2019-2024 ( USD Billion )
  4. North America Others Market By Region, From 2019-2024 ( USD Billion )
  5. North America Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Billion )
  6. North America Pediatrics Market By Region, From 2019-2024 ( USD Billion )
  7. North America Adults Market By Region, From 2019-2024 ( USD Billion )
  8. United States Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Billion )
  9. United States Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Billion )
  10. Canada Dendritic Cell Cancer Vaccines Market By Product Type, From 2019-2024 ( USD Billion )
  11. Canada Dendritic Cell Cancer Vaccines Market By End User, From 2019-2024 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample